PRECISION CAPITAL
ADVANCING
PRECISION HEALTH™
A PURPOSE-BUILT VENTURE FIRM
We combined accomplished investment professionals and operators with a proprietary national medical network platform to create the most unique venture firm in life sciences. MEC deploys precision capital to nurture and advance the precision health innovations that solve the biggest, most complex medical problems.
ADVANCING THE PRECISION HEALTH DECADE
At MEC, we believe the technologies created in this decade will lead to a golden age in innovation within the life sciences space. MEC invests in company creation, seed, Series A, and Series B opportunities where technology and novel approaches are transformative for patient care and directly address large, unmet needs. Our areas of focus include, but are not limited to:
AI TO
ADVANCE DRUG
DISCOVERY
ADVANCE DRUG
DISCOVERY
CELL AND GENE THERAPY
PRECISION MEDICINE
REGENERATIVE MEDICINE
SYNTHETIC BIOLOGY
OUR PORTFOLIO

Aspen Neuroscience
Active

Immunitas Therapeutics
Active

Nobias Therapeutics
Active

ProJenX
Active
TAKE THE NEXT STEP
Contact us today for more information about MEC.